All lobbying filings

RED+BLUE STRATEGIES

Lobbying for DAVITA INC. · A leading provider of dialysis services in the United States.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $70,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 2

HR 2199
Restore Protections for Dialysis Patients Act
S 1173
Restore Protections for Dialysis Patients Act

Lobbying activity 1

Health Issues

H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Exclusion of skin substitute spend from PY 2025 Comprehensive Kidney Care Contracting (CKCC) Kidney Care Entities (KCE) benchmarks.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.